Trials / Completed
CompletedNCT01470573
Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo
Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Autologous Cells of Sclerocorneal Limbus Amplified ex Vivo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Progenitor limbo sclerocorneal cells have properties of proliferation and differentiation to corneal and conjunctival epithelium. This cells can be isolated and ex vivo expanded using cell culture technics that could permit the biological replacement of damaged ocular surface.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | biological replacement corneal surface | the expanded tissue will be applied to patient to replace the damaged ocular surface |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2011-11-11
- Last updated
- 2012-12-10
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01470573. Inclusion in this directory is not an endorsement.